136-150 of 878
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
AudioAbstractsUnderstanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
Ryan Quigley
Understanding Crossover and Endpoints in ASCENT-03 and -04
Project Oncology®Understanding Crossover and Endpoints in ASCENT-03 and -04
Jennifer Caudle, DO, FACOFP
Neil M. Iyengar, MD
Bridging Gaps with Blood-Based CRC Screening
On the Frontlines of Colorectal CancerBridging Gaps with Blood-Based CRC Screening
Ryan Quigley
Aasma Shaukat, MD, MPH
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
On the Frontlines of Colorectal CancerEvolving Strategies in CRC Care: Screening, Treatment, and Equity
Ryan Quigley
Thomas Cataldo, MD
Sowmya Sharma, MD
Prioritizing Quality of Life in CRC: Key Surgical Considerations
On the Frontlines of Colorectal CancerPrioritizing Quality of Life in CRC: Key Surgical Considerations
Ryan Quigley
Thomas Cataldo, MD
Sowmya Sharma, MD
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Jennifer Caudle, DO, FACOFP
Mansi R. Shah, MD
- advertisement
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Ryan Quigley
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Project Oncology®Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Pavani Chalasani, MD, MPH
Virginia Borges, MD
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®Predicting Breast Cancer Metastasis with Proteomics
- advertisement
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®Advancing HER2-Targeted Therapy in GI Cancers
John H. Strickler, MD
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast CancerHER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP
Heather Parsons
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®How AI Is Transforming Biomarker Development in GI Oncology
William Hall, MD
